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Summary 1 
Data on husbandry practices, performance, disease and drug use were collected using 2 
detailed questionnaires during a cross-sectional survey of 89 poultry meat farms in 3 
England and Wales to provide information on possible risk factors for the occurrence 4 
of fluoroquinolone (FQ) resistant bacteria on poultry meat farms. Faeces samples 5 
taken as part of the surveys were used to classify farms as ‘affected’ or ‘not affected’ 6 
by FQ-resistant E. coli or Campylobacter spp., and statistical analyses were 7 
performed to identify factors associated with the farms’ FQ resistance status. 8 
The use of FQ on the farms was by far the most important factor influencing the 9 
occurrence of FQ-resistant bacteria. Resistant E. coli and/or Campylobacter spp. were 10 
found on 86% of the farms with a reported history of FQ use. However, resistant 11 
bacteria were also found on a substantial proportion of farms with no history of FQ 12 
use, suggesting that resistant organisms may spread between farms. Further analysis 13 
suggested that there are differences in the importance of various factors between the 14 
two organisms. For Campylobacter spp., on-farm hygiene, cleaning and disinfection 15 
between batches of birds and wildlife control were of most significance. For E. coli, 16 
biosecurity factors protecting the premises from outside contamination were of 17 
particular importance, although the statistical modelling indicated that other factors 18 
are likely to be involved. Detailed studies on a small number of poultry sites showed 19 
that FQ-resistant E. coli can survive routine cleaning and disinfection, so this must be 20 
of a high standard to reduce the persistence of resistant organisms on the farm.  21 
It appears difficult to avoid the occurrence of resistant bacteria when FQ are used on a 22 
farm, but the present findings provide evidence to support recommendations to reduce 23 
the substantial risk of the incidental acquisition of such resistance by farms where FQ 24 
are not used. 25 
26 
 3 
Introduction 27 
Antimicrobial resistance amongst farm strains of enteric zoonotic bacteria, such as 28 
E. coli and thermotolerant Campylobacter spp., is of concern, particularly in view of 29 
the risk it presents for human disease, persistent enteric colonisation and 30 
(theoretically) transmission of resistance to other enteric bacteria 31 
(ECDC/EFSA/EMA, 2015). E. coli is a ubiquitous enteric commensal in both human 32 
and veterinary species, with a small subset of strains that present veterinary, human 33 
and cross-species disease hazards due to particular colonisation factors and/or toxins 34 
(Hartl and Dykhuizen, 1984). Campylobacter spp. are the most commonly identified 35 
human gastrointestinal pathogens reported in the European Union, confirmed in over 36 
220000 cases in 2011 (EFSA/ECDC, 2013). 37 
 38 
In recent community-wide data from the European Union resistance to the 39 
fluoroquinolone (FQ) antibiotic ciprofloxacin was found to be high (44% to 78% of 40 
isolates overall, depending on source and subspecies) among Campylobacter jejuni 41 
and Campylobacter coli isolates from human (mostly clinical) and broiler 42 
(monitoring) sources (EFSA/ECDC, 2014). A survey of 145 Campylobacter spp. 43 
isolates from human, milk, poultry and cattle sources in Italy similarly found 63% 44 
exhibiting ciprofloxacin resistance but comparatively little resistance to other tested 45 
antimicrobials, with the exception of tetracycline (Di Giannatale et al., 2014). A 46 
survey in Chile revealed a similarly high frequency of ciprofloxacin resistance among 47 
poultry and human Campylobacter spp. isolates (around 60%), whilst only 18% of 48 
isolates from cattle were resistant (Gonzalez-Hein et al., 2013). For Campylobacter, 49 
all these data are in the context of subtyping studies indicating that 50% to 80% of 50 
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human cases may be linked, directly or indirectly, to the chicken reservoir, and of FQ 51 
being one of the principal drugs of choice for treating human campylobacteriosis 52 
(Agunos et al., 2013; EFSA, 2010).  53 
 54 
Aggregated European Community data for E. coli isolates from broilers showed, 55 
similarly to Campylobacter spp., that over 50% of isolates were resistant to 56 
ciprofloxacin (EFSA/ECDC, 2014). A sampling study provided evidence for the 57 
dissemination of individual and multiple antimicrobial resistances in E. coli from 58 
turkeys and broilers to their human handlers (van den Bogaard et al., 2001). 59 
Furthermore, FQ-resistant isolates from human bacteraemias and faeces were found to 60 
be more closely related to chicken isolates than to FQ-susceptible human isolates in 61 
another study (Johnson et al., 2006). 62 
 63 
Data from Australia, where FQ are restricted in the medical field and not used in food 64 
animals, has shown that FQ resistance among human Campylobacter spp. isolates has 65 
been slow to emerge, compared with other territories. Similarly, there is a low 66 
frequency of FQ resistance among Australian human disease-causing E. coli isolates 67 
(Cheng et al., 2012).  68 
 69 
Attempts at restricting antimicrobial resistance on farms have included various 70 
guidelines for the prudent use of veterinary antimicrobials (AAAP-AVMA, 2015; 71 
OIE, 2014; RUMA, 2005). However, these have been based in large part upon expert 72 
opinion, as published analyses of risk factors for the development of such resistances 73 
are lacking. 74 
 75 
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The present report details a risk factor analysis performed following a survey for the 76 
prevalence of FQ resistance among E. coli and Campylobacter spp. on poultry units in 77 
the UK. Questionnaire data was used in conjunction with the prevalence results to 78 
analyse FQ resistance with respect to a range of environmental and management 79 
factors. The overall prevalence results for poultry and pigs and the analysis for risk 80 
factors on pig farms have been reported elsewhere (Taylor et al., 2009, 2008) 81 
 82 
Materials and Methods 83 
Data collection 84 
Two programmes of sampling were undertaken. For the first, 89 poultry meat farms 85 
were included in a cross-sectional survey of FQ-resistant (FQr) E. coli and 86 
Campylobacter spp., the details of which are described elsewhere  (Taylor et al., 87 
2008). Briefly, 68 broiler and 21 turkey farms were each sampled once between June 88 
2001 and June 2003, with 64 separate fresh floor droppings being collected from 89 
random locations in up to four houses and combined into eight pools of eight samples 90 
each. The sample size and sampling strategy were designed to give a 95% probability 91 
of detecting resistant isolates if at least 5% of animals in the sampled houses were 92 
shedding resistant bacteria and laboratory detection was 90% sensitive. 93 
 94 
Sampling on poultry company premises was performed either by company-appointed 95 
poultry veterinarians or by poultry company staff under the supervision of the 96 
company veterinarian. Independent poultry producers (20 farms) carried out the 97 
sampling themselves. To provide information on possible factors associated with 98 
farms’ FQ resistance status, data about husbandry practices, performance, disease and 99 
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drug use, including use of non-FQ antibiotics, were collected using detailed 100 
questionnaires filled in by the farm manager with the veterinarian doing the sampling, 101 
or by independent producers themselves. Data on antibiotic use was acquired, in the 102 
large majority of cases and by all large units, by reference to detailed treatment 103 
records in the farm diaries. These records are audited regularly for the purposes of 104 
quality assurance and food chain protection. 105 
 106 
The second (follow-up) programme investigated the potential for dissemination and 107 
persistence of FQr organisms by carrying out farm-level sampling at representative 108 
stages of breeding and production networks in two integrated companies.  Faeces 109 
sampling and data collection were carried out by the farm manager, according to the 110 
protocols used for the first study, in five breeding flocks on repopulation, nine 111 
breeding flocks in mid to late lay and 28 broiler flocks in mid to late rear. On a 112 
selected proportion of sites where FQr organisms were found, intensive sampling was 113 
performed by staff from the research team to investigate the distribution of resistant 114 
E. coli on premises and to study their survival after cleaning and disinfection (C&D). 115 
Samples taken on VLA sampling visits included faeces, water, dust and surface swabs 116 
from building structures and equipment, as well as swabs from deep cracks in walls 117 
and floors. 118 
 119 
Bacteriology 120 
Bacteriological analysis of faeces pools was performed using liquid media (buffered 121 
peptone water [BPW] and Exeter’s Enrichment Broth for E. coli and Campylobacter 122 
spp., respectively) and selective solid media with added 1.0 mg/l ciprofloxacin 123 
(Chromagar ECC for E. coli; sheep blood agar plus Skirrow’s antibiotic supplement 124 
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and cefoperazone [BASAC] for Campylobacter spp.) as previously described (Taylor 125 
et al., 2008). Farms were thus classified as ‘affected’ or ‘not affected’ with respect to 126 
FQr E. coli or Campylobacter spp., using a selective concentration of ciprofloxacin 127 
that is similar both to contemporaneous tentative breakpoints (Luber et al., 2003; 128 
USDA, 2005), and  the current European clinical breakpoint (EUCAST, 2014). 129 
Putative E. coli colonies were confirmed using standard biochemical tests, 130 
campylobacters were identified to species level by standard microbiological 131 
procedures, and minimum inhibitory concentration (MIC) values of ciprofloxacin 132 
were determined as described elsewhere (Taylor et al., 2008). Non-faeces samples 133 
from intensive sampling visits in the second sampling programme were incubated in 134 
approximately 10-fold volumes of BPW (225 ml for surface swabs) and incubated as 135 
for faeces samples, before plating onto Chromagar ECC. Serotyping, toxin testing and 136 
antibiograms (not including FQ) by the disc diffusion method were carried out using 137 
standard protocols. 138 
 139 
Statistical analyses 140 
Statistical analyses were conducted using data from the first sampling programme 141 
only. Associations between FQ use and farm types, and between FQ use and the 142 
presence of FQr target organisms, were investigated using Chi-squared and Fisher’s 143 
exact tests. Calculations of relative risks associated with reported FQ use, with 95% 144 
confidence intervals, were carried out using EpiInfo version 6 (Centers for Disease 145 
Control and Prevention  U.S.A. & World Health Organisation, Geneva, Switzerland). 146 
 147 
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Correlation and cluster analyses and logistic regression modelling were carried out 148 
using SAS version 8 (SAS, 1999). The approach taken was exactly the same as that 149 
used in analysing data from pig farms (Taylor et al., 2009). Briefly, the questionnaire 150 
data were first placed in blocks according to subject matter (e.g. farm characteristics, 151 
farm hygiene, biosecurity, drug usage including other antibiotics) and then the 152 
variables within each block were screened using Ward’s minimum variance cluster 153 
analysis to identify groups of related variables (Everitt, 1980; Ward, 1963). From each 154 
group thus identified, a representative variable was selected (using epidemiological 155 
significance plus data variability and completeness as criteria) as a candidate 156 
explanatory variable in logistic regression modelling within each block of variables, 157 
with the presence on a farm of FQr E. coli or FQr Campylobacter spp. as outcome 158 
variables. 159 
By this method a number of candidate explanatory variables were identified from 160 
each block. These variables were re-analysed by Ward’s minimum variance cluster 161 
analysis regardless of their block of origin. Some variables closely correlated with 162 
other, more epidemiologically pertinent, ones were removed from the analysis at this 163 
stage. The retained candidate variables from all blocks were then tried together in 164 
logistic regression modelling, with results given as a list of risk factors for occurrence 165 
of FQ resistance in each bacterial species, quantified in terms of adjusted odds ratios. 166 
An r2 value, that estimates the proportion of variation in the data explained by the 167 
model, was calculated for each model, according to the method of Nagelkerke (1991) 168 
as recommended by Collett (2003). 169 
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Results 170 
Bacteriological findings 171 
First sampling programme. Findings have been reported in detail by Taylor et al. 172 
(2008). FQr E. coli were isolated from 53 of the 89 farms. FQr Campylobacter spp. 173 
were isolated from 20 of the 89 farms. Of tested isolates obtained from the 1.0 mg/ml 174 
ciprofloxacin screening plates used, 79% of E. coli and 70% of Campylobacter spp. 175 
isolates had MIC values for ciprofloxacin of 16 mg/l or greater. 176 
 177 
Second sampling programme. Of the five breeding flocks tested on repopulation in 178 
this follow-up investigation, none reported use of FQ during the previous six months 179 
or yielded FQr E. coli or Campylobacter spp.. Among the nine breeding flocks tested 180 
in mid- to late lay, FQr E. coli was isolated from two, but FQr Campylobacter spp. 181 
was not isolated. One of these nine flocks reported FQ use (in one of two houses) in 182 
the previous six months. Of the 28 broiler farms tested in mid-late rear, 25 yielded 183 
FQr E. coli. No FQr Campylobacter spp. was isolated. FQ had been administered 184 
during the previous six months on only one of these farms, in non-sampled parts of 185 
the farm, and all samples from this farm yielded FQr E. coli. 186 
 187 
Further intensive sampling visits, for FQr E. coli, were carried out at one of the mid-188 
lay breeding flocks, a linked company hatchery and after C&D on two of the 189 
commercial broiler sites. From the breeding flock, FQr E. coli was isolated from 16 of 190 
100 environmental samples. It was most frequently found in fresh faeces and litter 191 
(rather than nest boxes), but also found in guttering and on the concrete apron outside 192 
the house. At the hatchery, FQr E. coli was found in six of the 100 samples taken 193 
from meconium and egg/chick waste, as well as on cleaned and disinfected surfaces. 194 
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On both post-C&D broiler farms, FQr E. coli was found in cracks and crevices, 195 
pooled wash water, ante-rooms which had been less well disinfected and fresh 196 
droppings from wild birds collected from the house exterior. 197 
 198 
Seventy two E. coli strains from the second sampling programme were examined for 199 
MIC and serotype. Isolates were from breeder units in mid-lay, broiler units and the 200 
hatchery. Ciprofloxacin MIC values were ≥ 8 mg/l, with a modal value of 16 mg/l.  201 
Eight serovars were identified, and 12 isolates proved untypable. There was no 202 
overlap between identified serovars isolated from breeder versus broiler  flocks. Thus, 203 
there was no evident relationship between breeder and broiler isolates. One of the 204 
three serovars isolated from the hatchery was associated with the breeder flocks, and 205 
another with the broiler flocks. 206 
 207 
From one company, E. coli O101:K+ (verocytotoxin-negative, MIC 32 mg/l) was 208 
isolated in five broiler flocks in mid-late rear on one farm.. The same serovar was also 209 
found on two other farms from the same company, in two sequential flocks on each 210 
farm. FQr E. coli O9:K+ was isolated from two of the breeding flocks (MIC 8 mg/l) 211 
and from a waste skip at the hatchery (MIC 16 mg/l). However, this serovar was not 212 
amongst the isolates tested from broiler units within the company. 213 
 214 
The 72 serotyped E. coli isolates were also tested for resistance to antibiotics. Several 215 
patterns were found, with resistance to ampicillin (86% isolates), 216 
sulphamethoxazole/trimethoprim (65% isolates), tetracycline (67% isolates) and 217 
streptomycin (43% isolates) being the most frequently encountered, in addition to 218 
quinolone/FQ resistance. 219 
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 220 
Use of antibiotics and risk of fluoroquinolone resistance on the 221 
surveyed farms 222 
The questionnaire response options in relation to use of FQ on farms were: ‘within 12 223 
months’, ‘between one and two years ago’, ‘over two years ago’ and ‘never’. The 224 
responses are summarised in Table 1. Use of FQ was reported on 22 of 88 (25%) 225 
poultry farms in the survey, with one no-response. FQ use was significantly (Chi2 226 
p < 0.0001) more common on turkey farms (14/21) than on broiler farms (8/67). 227 
Among the broiler farms, FQ use was significantly (Chi2 p < 0.0001) more common 228 
by independent producers (7/18) than by large poultry company farms (1/49). 229 
Amongst turkey farms the most recent use had been within a year on nine of the 14 230 
farms that reported use. On broiler farms, only two of the eight reporting use of FQ 231 
had done so within the last year (Table 1). On all except one farm, FQ were 232 
administered through water medication. In turkeys, the most common problem treated 233 
with FQ was reported as being ‘E. coli septicaemia’. Amongst broilers, the most 234 
common problems reportedly associated with FQ use were ‘yolk sac infections’ or 235 
‘stunted chicks’. Use, in the previous 12 months, of non-FQ antibiotics other than 236 
amoxicillin (41% of farms), lincospectin (22% of farms) and tetracycline (10% of 237 
farms) was uncommon. Just under one fifth of farms reported routine use of in-feed 238 
antibiotic. 239 
 240 
FQr E. coli or FQr Campylobacter spp. were detected on 19 (86%) of the 22 farms 241 
that had used FQ and 40 (61%) of the 66 farms that reported never using FQ. The 242 
prevalence of farms positive for FQr E. coli or FQr Campylobacter spp. was not 243 
significantly different between farms with most recent use of FQ over one year ago, 244 
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compared with those using FQ within the last year. Therefore, farms where any FQ 245 
use was reported were grouped together for comparison with those farms reporting 246 
that they had never used FQ in further analyses. Table 2 shows the relative risks (with 247 
95% confidence intervals) for the occurrence of FQ resistance on poultry farms, 248 
associated with the use of FQ. 249 
 250 
Overall within-farm prevalence values for FQr Campylobacter spp. and E. coli were 251 
around 5% and 20% of faecal pools, respectively. On some premises, resistant 252 
Campylobacter were shed by birds in only one or two houses, but there were others 253 
where shedding birds were present across the farm. Birds shedding FQr E. coli tended 254 
to be distributed throughout the houses on affected farms. 255 
 256 
Modelling of risk factors for the occurrence of FQ-resistance 257 
Correlation and clustering analysis revealed that farm type (turkey or broiler; 258 
independent grower or large company) was strongly correlated with several of the 259 
variables. Specifically: 260 
 Turkey farms were strongly positively correlated with the use of FQ, cleaning 261 
and disinfecting header tanks, seeing more than five rats at depopulation, the use 262 
of plastic drinkers for chicks, and the use of growth promoters and tetracyclines. 263 
 Turkey farms were strongly negatively correlated with single-handed operation, 264 
enclosure by a perimeter fence, the provision of wheel dips, wild bird access to 265 
poultry houses, the presence of dogs or cats, cleaning and disinfecting ante 266 
rooms, feed hoppers and areas outside houses, and the use of nipple drinkers and 267 
digestive enzymes. 268 
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 Independent farms were strongly positively correlated with the use of FQ, the 269 
presence of dogs or cats, slaughtering birds at an older age and cleaning and 270 
disinfecting ante rooms. 271 
 Independent farms were strongly negatively correlated with the provision of 272 
masks and wheel dips, seeing more than five rats at depopulation, cleaning and 273 
disinfecting header tanks, and the use of digestive enzymes and growth 274 
promoters. 275 
 276 
In addition, the correlation analysis indicated the following: 277 
 Single-handed farms tended not to have wheel dips. 278 
 Farms enclosed by a perimeter fence tended to provide wheel dips and have 279 
dogs or cats. 280 
 Farms enclosed by a perimeter fence tended not to have big houses, tended not 281 
to be turkey farms and, therefore, tended not to use growth promoters and 282 
tetracycline. 283 
 Larger farms tended to provide masks to staff. 284 
 Dusting of all detailed areas was positively correlated with wet cleaning of all 285 
detailed areas and removal of all wash water from the site. 286 
 C&D of ante rooms was strongly positively correlated with C&D of feed 287 
hoppers. 288 
 In this particular sample of poultry farms, the variable ‘provision of a mask’ was 289 
also positively correlated with provision of hat and gloves and provision of hand 290 
sanitiser and provision of a toilet. 291 
 292 
 14 
The turkey farm type was very strongly associated with the use of FQ. The turkey 293 
farm variable itself was not significant in the final models. This implies that the 294 
reason for the increased proportion of turkey farms with FQr E. coli or 295 
Campylobacter spp., compared with broiler farms, as reported previously (Taylor et 296 
al., 2008), is fully explained by other variables in the model, chiefly the use of FQ on 297 
the farms. 298 
 299 
The results of the final regression modelling are presented in tables 3 and 4 showing 300 
the variables included as risk factors, estimates of coefficients with p-values, the 301 
estimated adjusted odds ratios with 90% and 95% confidence intervals and the r2 302 
value.  303 
 304 
Having fitted main effects, several interactions were identified as statistically 305 
significant but inclusion of these in the regression models always resulted in estimates 306 
for some odds ratios approaching infinity or zero. This was considered to be the result 307 
of small sample sizes, such that inclusion of too many effects, notably the 308 
interactions, produced models that were ‘over-fitted’, as described by Collett (2003). 309 
To avoid the possibility of over-fitting and implausible interpretations, models were 310 
finalised without interactions. 311 
 312 
Table 3 provides a summary of the factors included in the final fitted logistic 313 
regression model for the risk of occurrence of FQr E. coli. Significant factors 314 
increasing risk are: use of FQ in past, single-handed operation of the site, and the 315 
existence of a public footpath on the periphery of the site. The sole significant factor 316 
decreasing risk is enclosure of the site by a perimeter fence. The r2 value of the fitted 317 
 15 
model is fairly low, which indicates that other, unidentified, explanatory risk factors 318 
are likely to be involved. 319 
 320 
Table 4 provides a summary of the factors included in the final fitted logistic 321 
regression model for the risk of occurrence of FQr Campylobacter spp. Significant 322 
risk factors increasing risk are: the use of FQ in the past and wild birds having access 323 
to poultry houses. Significant factors decreasing risk are: more than the median (for 324 
all broiler or turkey farms in the sample, as appropriate) number of birds on site, the 325 
site operated by an independent grower, masks provided for staff, detailed areas 326 
dusted before wet cleaning, and feed hoppers cleaned and disinfected. 327 
 328 
The r2 value is over 50%, indicating that the model provides a good explanation of 329 
factors affecting the occurrence of FQ-resistant Campylobacter spp.. However, the 330 
model is fitted with quite a large number of variables (seven) in relation to the dataset 331 
size (n = 84) and is in danger of being ‘over-fitted’. The result of this is the relatively 332 
wide confidence intervals for the adjusted odds ratios. Nevertheless, the fitted 333 
variables are statistically significant. The conclusion is that the factors in the model 334 
affect risk significantly, and perhaps greatly, but the data are not sufficient to allow 335 
the risk effect to be quantified very precisely. 336 
 337 
Discussion 338 
The bacteriological findings of the initial survey (Taylor et al., 2008) and the follow-339 
up studies reported here have identified the frequent occurrence of  E. coli and 340 
Campylobacter spp. with FQ resistance on a substantial proportion of turkey and 341 
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broiler commercial production facilities. FQr E. coli were also isolated on breeding 342 
flock premises. Moreover, the FQr E. coli and Campylobacter spp. typically exhibited 343 
clinically-significant elevations in MIC values (Becnel Boyd et al., 2009; EUCAST, 344 
2014) and the FQr E. coli often showed resistance to other classes of antimicrobial 345 
agents. The present findings for E. coli are similar, in terms of frequency of isolation 346 
on FQ resistance-selective media, MIC values observed, and common co-resistances 347 
with other classes of antimicrobial drugs, with the findings of Gosling et al. (2012). 348 
That study used UK-wide samples from turkey units taken for a European Union 349 
baseline survey. 350 
 351 
It was initially hypothesised that FQr organisms would be found on a small 352 
percentage of farms, principally those where FQ were used. However, in the first 353 
(structured) survey FQr organisms (mostly E. coli) were detected on a heavy majority 354 
(86%) of farms that had used FQ in the past, and also on over half (61%) of the farms 355 
that reported never using FQ. This finding is similar to that of a concurrent survey in 356 
pig production (Taylor et al., 2009). A history of FQ use was associated with an 357 
approximately doubled risk that FQr E. coli or Campylobacter spp. would be found on 358 
a farm, and with the highest odds ratios among all the factors considered in the 359 
logistic regression models for FQ resistance on farm.   360 
 361 
The substantial prevalence of FQ resistance-affected farms that had never used FQ 362 
suggests that FQr organisms may commonly be imported onto farms, either with 363 
replacement birds in the case of E.coli, or from environmental sources in the case of 364 
Campylobacter spp.. The persistence of such strains correlates with experimental data 365 
suggesting little or no fitness cost associated with a moderate degree of FQ resistance 366 
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in E. coli (Schrag et al., 1997) and Campylobacter spp. (Q. Zhang et al., 2003). This is 367 
consistent with the experience in countries where FQ are either prohibited or not 368 
specifically licensed in poultry farming (USA, Canada and Denmark), where FQ 369 
resistance among Campylobacter spp. isolates from poultry sources has not 370 
consistently declined following cessation of FQ use in the sector (Agunos et al., 2013; 371 
DANMAP, 2014). 372 
 373 
There are, inevitably, some reasons to be careful in interpreting the present analysis. 374 
The influence of co-resistance involving FQ resistance plus other antibiotics needs 375 
some consideration, despite no significant associations being found between FQ 376 
resistance on premises and recent use of a specific antibiotic class.  377 
 378 
In Campylobacter spp., resistance to FQ typically is mediated by mutation of a 379 
chromosomally-encoded topoisomerase, which is a mechanism specific to quinolone 380 
antibiotics (Gyles, 2008; Qijing Zhang et al., 2003). This is augmented in some cases 381 
by overexpression of the chromosomally-encoded multi-drug efflux pump CmeB 382 
(Fàbrega et al., 2008). Therefore, clinical resistance to FQ is unlikely to occur 383 
consequent upon use of a different antibiotic class or by introduction on mobile 384 
genetic elements. However, as shown in the present study and elsewhere (Pérez-Boto 385 
et al., 2013), FQ resistance in Campylobacter spp. from poultry farms is often 386 
accompanied by other antibiotic resistances in the same isolates. If FQ resistance is, 387 
for whatever reason,  more common amongst antibiotic-resistant strains than among 388 
susceptible strains, then co-selection by other antibiotics may maintain pre-existing 389 
FQr strains for a prolonged period, especially if , as appears to be the case, the fitness 390 
cost of FQ resistance among Campylobacter spp. is low (Luo et al., 2005). It is 391 
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therefore important to note that, whereas FQ resistance clearly has the potential to 392 
persist in the absence of FQ use by co-selection, it seems unlikely to be present in the 393 
first instance without either being introduced from elsewhere, or following selection 394 
by FQ use. 395 
 396 
For E. coli, the picture is perhaps more complicated. High-level FQ resistance is 397 
firmly associated with topoisomerase mutation(s) (Fàbrega et al., 2008; Gyles, 2008; 398 
Vanni et al., 2014), although intermediate resistance or enhancement of clinical 399 
resistance is possible by chromosomal efflux pump upregulation and/or plasmid-borne 400 
genes encoding target site protection (qnr), efflux (qepA) or FQ modification by an 401 
aminoglycoside acetyltransferase  (aac(6′)-Ib-cr) (Fàbrega et al., 2008; Veldman et 402 
al., 2011; Yue et al., 2008). Therefore, intermediate FQ susceptibility may be 403 
introduced or maintained by horizontal transfer and/or co-selection by the use of other 404 
antibiotic classes. However, no non-FQ antibiotics are likely to select the spontaneous 405 
topoisomerase mutations fundamental to clinical resistance levels. 406 
 407 
Although the prevalence of FQ resistance among contemporaneous diagnostic avian 408 
samples of E. coli in the UK was low (around 2% to 6% depending on region and 409 
source), resistances to commonly-used antimicrobials were more prevalent, in the 410 
range 23% to 65% of isolates for ampicillin, amoxicillin, spectinomycin and 411 
trimethoprim/ sulphonamide (Anon., 2007), consistent with the resistance findings in 412 
the present study. This suggests that many FQ-resistant E. coli would also have had 413 
resistance to other therapeutic antibiotics. Like Campylobacter spp., this might 414 
facilitate co-selection of FQ resistance by other antibiotics but would not be expected 415 
to generate de novo the clinical degree of resistance seen in the present study.  416 
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The second sampling programme and typing studies reinforce the finding of the initial 417 
survey that the presence of FQr E. coli on a farm may not necessarily be related to 418 
recent recorded use of FQ on the premises. The FQr E. coli isolated belonged to 419 
numerous serogroups and had a range of different antibiograms, indicating that they 420 
did not belong to a single clone. Furthermore, the FQr E. coli on the two farms tested 421 
after C&D were able to persist in the environment and were a potential source of 422 
infection for a new flock. A pertinent allied observation from the initial survey is that, 423 
on farms where FQ had been used, there was no significant effect seen of the time 424 
elapsed since last use upon the risk of FQ resistance. It is  interesting to note in this 425 
context that Ingram et al. (2013) isolated FQr E. coli harbouring multidrug-resistance 426 
plasmids from chicken carcasses in Australia (a territory where FQ are not licensed 427 
for poultry), thereby showing that topoisomerase-mutants may be present commonly 428 
in products from apparently FQ-free systems. 429 
 430 
The second sampling study also provided observational evidence that, for E. coli at 431 
least, FQr strains potentially can transfer between broiler premises within integrated 432 
operations, presumably via personnel and fomites. There was no evidence of vertical 433 
transmission of FQr E. coli from breeder to broiler flocks, which may reflect the 434 
biosecurity barrier that can be achieved between these levels of production by 435 
hygienic hatchery management. 436 
 437 
The differences in risk factors identified for the two bacterial genera examined may 438 
reflect differences in the usual modes of transfer of these organisms between 439 
locations. Interested readers are directed to Taylor et al. (2009) for discussion of the 440 
merits and limitations of the statistical modelling approach of the present study. In 441 
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addition to FQ use and single-handed operation, the two variables identified as 442 
significant risk factors for the occurrence of FQr E. coli were the existence of a 443 
perimeter fence (protective) and of a public footpath (increasing risk). Thus, in 444 
common with pig units, biosecurity appears to be of high importance for FQr E. coli. 445 
For poultry the physical integrity of the farm limits seems to be of primary 446 
significance, whereas for pigs the proximity of  other pig units and visitor biosecurity 447 
was found to be important (Taylor et al., 2009). 448 
 449 
These differences in the most significant biosecurity barriers for pigs versus poultry 450 
farms may to some extent reflect differences in the frequency of visitors and of feed 451 
and stock transporters, differences in the housing systems, in the typical farm sizes, 452 
and in the typical local environments. Whilst risk factor analysis may identify areas of 453 
particular vulnerability or strength for particular enterprise types, examination of any 454 
particular unit would sensibly include a comprehensive overview of biosecurity 455 
issues, especially as the relatively low r2 value for the E. coli model indicates other 456 
significant unidentified risk factors that may not be common to all or most units. 457 
 458 
For Campylobacter spp., the risk factor model for the occurrence of FQ resistance 459 
indicates the importance of farm hygiene, perhaps reflecting the greater importance of 460 
shorter-range transmission between animals for this more environmentally labile 461 
pathogen when compared with E. coli. One protective factor of particular interest was 462 
provision of a mask. This factor was positively correlated with, and effectively a 463 
proxy variable for, other factors including the provision of hand sanitisers, a toilet, 464 
hats and gloves. The inclusion of this factor in the model can be taken as indication of 465 
the protective effect of better hygiene facilities in general. 466 
 21 
 467 
The significantly protective variables regarding dusting (of several difficult or 468 
inaccessible parts of poultry houses before wet cleaning) and C&D of feed hoppers 469 
are interpreted as indicators of generally superior farm cleaning. Campylobacters are 470 
frequently recovered from puddles and other wet locations on farms, but typically not 471 
from dry materials. The findings indicate the importance of attention to detail when 472 
cleaning between crops, presumably by preventing carry-over of infection, 473 
particularly of Campylobacter spp., between batches of stock. 474 
 475 
The introduction of Campylobacter spp. (including, potentially, FQr strains) to a 476 
poultry flock or premises is considered to be a more important issue than carry-over, 477 
and may occur following the repeated entrance of staff with contaminated clothing, 478 
hands or equipment (Newell et al., 2011). The risks of acquisition of Campylobacter 479 
spp. by flocks before slaughter are related to several factors including: season, on-480 
farm hygiene, other animal species on the farm, more than one poultry house per 481 
stockperson, thinning of slaughter-age flocks by catching crews and features of the 482 
farm environmental surroundings, as reviewed by Vidal et al., (2014). However, 483 
Refregier-Petton et al. (2001) reported a risk factor analysis for the presence of 484 
Campylobacter spp. in broilers at slaughter using a similar methodology to the present 485 
one and found, amongst other things, that no specific stockperson hygiene practices 486 
were significant. Discrepancies noted in that report between claimed and observed 487 
hygiene practices may explain this finding, and its apparent lack of concordance with 488 
the present evidence. 489 
 490 
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The transmission of FQr Campylobacter spp., and probably of Campylobacter spp. 491 
more generally, may also be associated with wildlife vectors. Remarkable suppression 492 
of seasonal peaks in flock Campylobacter spp. colonisation has been demonstrated, in 493 
the context of good general hygiene, following the use of mesh screens to exclude 494 
wildlife down to the level of flying insects from broiler houses (Bahrndorff et al., 495 
2013). The factor, ‘saw more than five rats at last depopulation’ was associated with 496 
an increased risk, but was not significant in the final model. Access to the poultry 497 
houses by wild birds was a significant factor for increasing risk in the final model, 498 
with a large odds ratio. It has been documented that wild birds carry Campylobacter 499 
spp., including FQr strains (Broman et al., 2002; Waldenstrom et al., 2005), although 500 
wild bird strains generally differ from poultry and human strains (Broman et al., 501 
2004). Access by wild birds may be indicative of poorer biosecurity with respect to 502 
wildlife more generally. 503 
 504 
In conclusion, the present investigations have illustrated the strong association 505 
between any use of FQ on poultry farms and the presence of E. coli and/or 506 
Campylobacter spp. with clinically-relevant levels of resistance to FQ on the same 507 
premises. Furthermore, the introduction or maintenance of FQr organisms on farms 508 
appears significantly influenced by farm hygiene (Campylobacter spp.) and boundary 509 
biosecurity (E. coli), with evidence also being found of cross-transfer of FQr E. coli 510 
between premises linked in the production system. As has been discussed elsewhere 511 
(Taylor et al., 2008), both E. coli and Campylobacter spp. are zoonotic organisms for 512 
which FQ are therapeutic agents in humans. It appears, on the present evidence, to be 513 
difficult for farms that use FQ to avoid the development of FQ-resistant E. coli and 514 
Campylobacter spp. on farm. However, for those farms that do not use FQ, an 515 
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emphasis on excellence in biosecurity and on-farm hygiene is likely to prove 516 
protective. The benefits of such a strategy are likely to extend to control or exclusion 517 
of some other infectious agents also. This is in line with guidelines produced by the 518 
UK ‘Responsible Use of Medicines in Agriculture Alliance’ (RUMA; 519 
http://www.ruma.org.uk), which stress that the use of antimicrobials should be seen as 520 
complementing good management, vaccination and site hygiene. 521 
 522 
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Table 1: Detection of fluoroquinolone (FQ)-resistant bacteria on poultry farms, 
compared with reported use of FQ 
Last use of FQ 
antibiotics 
Broiler 
farms 
Turkey 
farms All farms 
Number with FQ resistance 
E. coli Campylobacter 
In last year   2 9 11 10  (91%)   4  (36%) 
Over 1 year ago   6a 5b 11   9  (82%)   4  (36%) 
Never used 59 7 66 33  (50%) 11  (17%) 
a: 2 of 6 reported most recent use over 2 years ago 
b: 1 of 5 reported most recent use over 2 years ago 
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Table 2: Relative risks (with 95% confidence intervals) for the occurrence of 
fluoroquinolone (FQ) resistance on poultry farms, associated with the reported 
use of FQ 
 Proportion of farms with FQ resistance 
 E. coli Campylobacter 
FQ used (n = 22) 0.86 0.36 
FQ never used (n = 66) 0.50 0.17 
Relative Risk (95% C.I.) 1.73 (1.29 – 2.32) 2.18 (1.01 – 4.72) 
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Table 3: Estimated adjusted odds ratios, with confidence intervals (C.I.s), of variables 
included as risk factors in the final logistic regression model for the occurrence of 
fluoroquinolone (FQ)-resistant E. coli on poultry farms 
Risk Factor 
co-
efficient p-value* 
Lower Limit C.I.s 
Odds ratio 
point estimate 
Upper Limit C.I.s 
95% 90% 90% 95% 
Constant - 0.204 0.6294      
Use of FQ in the past 2.049 0.0016 1.85 2.31 7.76 26.04 32.48 
Site operated single-
handedly 
0.948 0.073 0.89 1.06 2.58 6.30 7.46 
Site enclosed by a 
perimeter fence 
- 1.302 0.014 0.09 0.11 0.27 0.67 0.79 
Site has public footpath 
on the perimeter 
1.407 0.019 1.17 1.43 4.09 11.67 14.20 
n = 83; maximum re-scaled r2 = 29.9% 
*p-value is based on likelihood ratio test. 
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Table 4: Estimated adjusted odds ratios of variables, with confidence intervals (C.I.s), of 
variables included as risk factors in the final logistic regression model for the occurrence of 
fluoroquinolone (FQ)-resistant Campylobacter spp. on poultry farms 
Risk Factor 
co-
efficient p-value* 
Lower limit C.I.s 
Odds ratio 
point estimate 
Upper limit C.I.s 
95% 90% 90% 95% 
constant 1.476 0.2387      
Use of FQ at any time 
in past 
2.685 0.0052 1.64 2.32 14.65 92.59 130.59 
No. of birds on site 
higher than median 
- 2.182 0.0097 0.02 0.024 0.11 0.54 0.73 
Site owned by an 
independent grower 
- 3.156 0.0031 0.00 0.005 0.04 0.36 0.54 
Masks provided for 
staff 
- 1.412 0.081 0.05 0.062 0.24 0.96 1.24 
All detailed areas are 
dusted 
- 2.147 0.0089 0.02 0.026 0.12 0.52 0.69 
Feed hoppers cleaned 
and disinfected 
- 1.684 0.061 0.03 0.041 0.19 0.85 1.13 
Wild birds have access 
to poultry houses 
2.332 0.017 1.40 1.91 10.30 55.46 76.05 
n = 84; maximum re-scaled r2 = 56.3% 
*p-value is based on likelihood ratio test. 
